Medicare Enrolled
Dr. Chandra Veluru, MD
Internal Medicine · Yuba City, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Veluru from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Veluru?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Veluru
Dr. Chandra Veluru is an internal medicine specialist in Yuba City, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Veluru performed 2,276 Medicare services across 1,879 unique beneficiaries.
Between the years covered by Open Payments, Dr. Veluru received a total of $2,037 from 15 pharmaceutical and/or device companies across 45 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Veluru is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 14% volume in CA
$2,037 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,276
Medicare services
Top 14% in CA for internal medicine
1,879
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~126 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
488 | $96 | $345 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
344 | $91 | $343 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
214 | $206 | $2,234 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
198 | $141 | $663 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
195 | $115 | $521 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
116 | $62 | $238 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
101 | $78 | $1,226 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
91 | $72 | $1,390 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
73 | $53 | $240 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
68 | $89 | $1,868 |
| Moderate sedation during GI endoscopy Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient. |
53 | $4 | $247 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
46 | $173 | $1,597 |
| Radiologist review of bile duct tube placement imaging A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope. |
41 | $19 | $182 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
36 | $162 | $1,892 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $68 | $344 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
30 | $142 | $1,586 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $63 | $234 |
| Endoscopic incision of pancreatic outlet A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet. |
21 | $28 | $1,621 |
| Upper endoscopy of small intestine A diagnostic procedure using a flexible tube with a camera to examine the upper part of the small intestine. |
21 | $66 | $673 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $104 | $450 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
19 | $88 | $775 |
| Pancreatic or bile duct stent insertion A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open. |
15 | $370 | $1,900 |
| Small bowel biopsy via endoscope A procedure to collect tissue samples from the small intestine using an endoscope. The sample is taken from the small bowel, excluding the ileum. |
13 | $70 | $730 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
11 | $185 | $1,617 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
20.9% medium
78.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,037
Total received (2018-2024)
Avg $407/year across 5 years
Top 26% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
45
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,021 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$968
2023
$346
2022
$218
2019
$488
2018
$17
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$245
PFIZER INC.
$138
Janssen Biotech, Inc.
$134
Madrigal Pharmaceuticals
$133
GENZYME CORPORATION
$133
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Lilly USA, LLC
$44
Takeda Pharmaceuticals U.S.A., Inc.
$42
Gilead Sciences, Inc.
$22
Braintree Laboratories, Inc.
$18
Top 3 companies account for 53.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$326
Gilead Sciences, Inc.
$250
GENZYME CORPORATION
$245
PFIZER INC.
$154
Janssen Biotech, Inc.
$134
Madrigal Pharmaceuticals
$133
AbbVie, Inc.
$130
AbbVie Inc.
$122
Alexion Pharmaceuticals, Inc.
$114
Regeneron Healthcare Solutions, Inc.
$112
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$102
QOL Medical, LLC
$94
Takeda Pharmaceuticals U.S.A., Inc.
$59
Lilly USA, LLC
$44
Braintree Laboratories, Inc.
$18
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
DUPIXENT · ENTYVIO · Entyvio · Epclusa · LINZESS · OMVOH · REZDIFFRA · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · TREMFYA · TRULANCE · VELSIPITY · XELJANZ · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
82
Per 100K population
82.9
County median income
$75,450
Nearest hospital
SUTTER SURGICAL HOSPITAL - NORTH VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Veluru is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Veluru experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Veluru performed 488 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Veluru receive payments from pharmaceutical companies?
Yes. Dr. Veluru received a total of $2,037 from 15 companies across 45 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Veluru's costs compare to other internal medicine physicians in Yuba City?
Dr. Veluru's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Veluru) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Yuba City
Browse internal medicine physicians in Yuba City ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology